[Effect of heterocyclic lipolysis inhibitors on the activity of 3',5'-AMP-phosphodiesterase].
D000255:Adenosine Triphosphate / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology*; D000818:Animals; D002417:Cattle; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008055:Lipids / Q000037:antagonists & inhibitors*; D009539:Nicotinic Acids / Q000494:pharmacology*; D010080:Oxazoles / Q000494:pharmacology*; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011720:Pyrazoles / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology
D000960:Hypolipidemic Agents; D008055:Lipids; D009539:Nicotinic Acids; D010080:Oxazoles; D011720:Pyrazoles; D000255:Adenosine Triphosphate; D013806:Theophylline; D010744:Phosphoric Monoester Hydrolases
Wirkung von heterocyclischen Lipolysehemmstoffen auf die Aktivität der 3',5'-AMP-Phosphodiesterase.